| Clinical data | |
|---|---|
| Other names | RS-2386; Fluocinolone acetonide 21-cyclopropylcarboxylate; 6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-cyclopropanecarboxylate; 6α,9α-Difluoro-11β,21-dihydroxy-16α,17α-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione 21-cyclopropanecarboxylate |
| Drug class | Corticosteroid;Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.055.715 |
| Chemical and physical data | |
| Formula | C28H34F2O7 |
| Molar mass | 520.570 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ciprocinonide (developmental code nameRS-2386), also known asfluocinolone acetonide cyclopropylcarboxylate, is asyntheticglucocorticoidcorticosteroid which was never marketed.[1]